OrganaBio, LLC (“OrganaBio”), a manufacturer of GMP cells and blood products and provider of cell isolation and cryopreservation services, has acquired substantially all of the operating assets of San Diego-based Excellos Inc. to create a bicoastal cell therapy contract development and manufacturing organization. Newly formed OrganaBio subsidiary Excellos Labs, LLC (“Excellos Labs”) will be responsible for San Diego operations going forward. The acquisition creates a more comprehensive cell therapy service provider, combining complementary capabilities in addition to expanding geographic coverage.
Read the full article: OrganaBio Acquires Excellos Operating Assets, Establishing a Coast-to-Coast Cell Therapy Contract Testing, Development and Manufacturing Organization //
Source: https://www.businesswire.com/news/home/20260513516778/en/OrganaBio-Acquires-Excellos-Operating-Assets-Establishing-a-Coast-to-Coast-Cell-Therapy-Contract-Testing-Development-and-Manufacturing-Organization